首頁 > 市場調查報告書 > 工業機械

市場調查報告書

商品編碼

1456902

生物安全櫃市場 - 2024年至2029年預測

Biological Safety Cabinet Market - Forecasts from 2024 to 2029

出版日期: 2024年02月27日 | 出版商:

Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

2022年生物安全櫃市場價值為138,221,000美元，預計複合年成長率為6.16%，到2029年市場規模將達到210,036,000美元。

生物安全櫃是實驗室和實驗室使用的封閉櫃，用於保護科學家和實驗室人員免受污染材料處理過程中產生的生物危害和傳染性物質的影響。該櫃子配備了高效能顆粒過濾器 (HEPA)，可去除實驗室空氣中的病毒和細菌等傳染源。由於其高安全性和高性能，在製藥公司和研究機構的檢測和診斷實驗室具有很高的適用性。

由於對新藥和有效療法的需求不斷成長，促進了製藥業的成長，公司和政府組織的有利投資流入對生物安全櫃市場的成長產生了積極影響。預計此類投資將增加藥物測試應用中對生物安全櫃的需求，並在預測期內提振櫃市場。

市場趨勢：

與傳統 PSTN 服務相比，基於 IP 的服務擴大被採用，預計將在預測期內推動市場成長。雲端運算使用量的增加、雲端運算的快速採用以及企業整合通訊（UC）系統等因素預計將增加對生物安全櫃的需求並推動整體市場成長。生物安全櫃市場按公司規模、最終用戶和地區細分。依公司規模，公司分為小型、中型和大型。依最終用戶分類，可分為通訊/技術、醫療、零售、BFSI、政府等。

市場促進因素：

隨著生命科學產業的良好投資流入和合作研究，生物安全櫃的需求預計將激增。

高安全性生物安全櫃主要用於生物實驗室、研究、微生物學等人員及環境保護。製藥公司正在投資新藥和疫苗，並結成策略聯盟，以解決患有重大疾病的人們未滿足的需求。此外，2022 年 3 月，Blackstone Life Sciences 與賽諾菲建立策略夥伴關係，開發多發性骨髓瘤的治療方法。預計此類設施和投資將刺激對生物安全櫃的需求並在預測期內促進市場成長。

對實驗室安全的日益關注預計將對市場產生積極影響。

人們對實驗室安全的日益關注對生物安全櫃市場產生了重大影響，這推動了對這些基本安全殼系統的需求激增。隨著實驗室和研究機構優先考慮員工的健康並努力降低與處理生物材料相關的風險，平衡計分卡已成為安全通訊協定的重要組成部分。

嚴格遵守生物安全法規和指南顯示了我們對實驗室安全的重視。 BSC 專為滿足這些嚴格標準而設計，提供受控環境，避免測試和加工過程中的污染和交叉污染。人們對可能的風險的認知不斷提高，推動了最先進的生物安全櫃技術的採用，並強調了對可靠的遏制解決方案的需求。

市場限制因素：

生物安全櫃產業面臨重大限制，可能會影響更廣泛的接受度。一個主要挑戰是購買、安裝和認證生物安全櫃的初始成本較高。所需的巨額支出可能令人望而卻步，特別是對於預算有限的實驗室和醫療機構。

總擁有成本進一步受到持續營運和維護成本的影響，例如頻繁的認證和測試以確保符合安全法規。這種成本負擔可能會影響資源有限的小型實驗室和設施的決策流程。此外，身份驗證和頻繁維護的需要可能會導致停機，從而擾亂醫院、研究設施等的持續運作。

生物安全櫃預計將成為成長最快的部分。

生物安全櫃依類別分為一類、二類、三類。在生物安全櫃市場的預測期內，II類生物安全櫃預計將出現相對較高的成長率。 II級生物安全櫃常用於基礎研究和檢測活動，並配有HEPA過濾器，因此櫃體可以為產品、人員和環境提供更好的保護。隨著更多用於生產和測試新藥的研發設施的建立，對此類櫃子的需求預計將會增加。此外，由於開發新藥的各種研發投入，預計II級生物安全櫃的需求也會增加。

亞太地區預計將成為主要區域市場

隨著生物技術和生命科學研究的快速擴張，亞太生物安全櫃市場受到多種因素的推動。隨著該地區基因研究、藥物開發和診斷設施的迅速增加，必須制定強力的生物安全通訊協定。政府計劃和大量研發支出進一步增強了對生物安全櫃的需求，這符合該地區促進創新和科學發展的承諾。

由於人們越來越認知到處理生物材料的潛在危險以及遵守國際生物安全標準的需要，醫療機構和實驗室正在將 BSC 納入其安全措施。亞太地區充滿活力的科學研究領域凸顯了平衡計分卡作為確保安全職場的重要手段的重要性，從而導致許多領域生物安全通訊協定的擴展和改進。

主要進展

2023年6月，labculture(R) G4 II級A2型生物安全櫃（LA2 G4）提高了生物安全櫃技術創新與完善的標準。這款最先進的生物安全櫃經過 NSF 認證的 BSC，為效率和安全性樹立了新標準。
2023 年 3 月，Labconco® 推出了更先進的微生物安全櫃 ReVoTM，擴大了其廣泛的生物安全產品範圍。 ReVo 是精心設計的新型 II 級 A2 型生物安全解決方案。

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 英國
- 德國
- 法國
- 西班牙
- 其他
中東/非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 其他
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 台灣
- 泰國
- 印尼
- 其他

第9章競爭環境及分析

主要企業及策略分析
市場佔有率分析
合併、收購、協議和合作
競爭對手儀表板

第10章公司簡介

Esco Micro Pte. Ltd
Kewaunee International Group
Thermo Fisher Scientific
Baker
Labconco
Germfree Laboratories Inc.（EW Healthcare Partners）
Nuarie（Genuit）
Euroclone SpA
Air Science

簡介目錄

Product Code: KSI061611765

The biological safety cabinet market is evaluated at US$138.221 million for the year 2022 and is projected to grow at a CAGR of 6.16% to reach a market size of US$210.036 million by the year 2029.

A biological safety cabinet is an enclosed cabinet used in laboratories and research centers to protect scientists and laboratory personnel from any biohazard or infectious agents that occur during the processing of contaminated materials. The cabinet is equipped with a highly efficient particle-arresting filter (HEPA) which removes infection agents such as viruses & bacteria from the air in the laboratory. Owing to its high safety and performance features, the biological safety cabinet holds high applicability in testing & diagnostic laboratories of pharmaceutical companies and research institutes.

The bolstering growth in the pharmaceutical sector, owing to the growing demand for new and effective medical drugs for diseases, and favorable investment inflows both by companies and government organizations have positively impacted the market growth of the biological safety cabinet. Such investments are predicted to increase the demand for biological safety cabinets during the drug testing application, thereby boosting the market for the cabinets during the forecast period.

MARKET TRENDS:

The rising adoption of IP-based services over traditional PSTN services is projected to boost the market growth during the forecast period. Factors such as increasing usage of cloud computing, rapid adoption of cloud, and unified communication systems by enterprises are expected to increase the demand for Biological safety cabinets, thus boosting the overall market growth. The Biological safety cabinet market has been segmented based on enterprise size, end-user, and geography. Based on enterprise size, the market has been segmented into small, medium, and large. By end-user, the market has been segmented into communication and technology, healthcare, retail, BFSI, government, and others.

MARKET DRIVERS:

Favorable investment inflows and collaborations in the life sciences industry are predicted to create a surge in the demand for biological safety cabinets.

Biological safety cabinet owing to their safety features is majorly used in biological laboratories, research, and microbiology for personnel as well as environmental protection. Various pharmaceutical companies are undergoing strategic collaborations as well as investments in new drugs and vaccine development that could cater to the unmet needs of people suffering from major diseases. Furthermore, in March 2022, Blackstone Life Sciences entered into a strategic collaboration with Sanofi, for the development of the treatment for multiple myeloma. Such establishment and investments are anticipated to stimulate the demand for biological safety cabinets, thereby boosting its market growth during the forecast period.

A rising focus on laboratory safety is predicted to positively influence the market.

The biological safety cabinets (BSCs) market is significantly impacted by the growing emphasis on laboratory safety, which fuels a spike in demand for these essential containment systems. BSCs are essential parts of safety protocols as labs and research facilities put workers' health first and work to reduce the hazards involved in handling biological materials.

The strict observance of the rules and guidelines controlling biosafety is indicative of the emphasis on laboratory safety. BSCs offer a controlled environment that avoids contamination and cross-contamination during tests and processes since they are particularly made to comply with these strict criteria. The adoption of cutting-edge BSC technologies is fueled by the increased awareness of possible risks, which highlights the necessity for dependable containment solutions.

MARKET RESTRAINTS:

There are significant limitations faced by the biological safety cabinet (BSC) industry that may affect its broader acceptance. The major challenge is the initial high expense of buying, installing, and certifying BSCs. The substantial monetary outlay that is necessary might be prohibitive for labs and medical facilities, especially those with tight budgets.

The total cost of ownership is further impacted by continuing operating and maintenance costs, such as frequent certification and testing to guarantee adherence to safety regulations. The decision-making process of smaller laboratories or institutions with limited resources may be impacted by this cost burden. Furthermore, the requirement for certification and frequent maintenance might cause downtime, which would disrupt the ongoing operation in settings like hospitals and research facilities.

The biological safety cabinet is anticipated to be the fastest-growing segment.

Based on class type, the biological safety cabinet is segmented into class I, class II, and class III. The class II type biological safety cabinet is expected to grow at a relatively higher rate during the forecast period of the biological safety cabinet market. Class II biological safety cabinet has high usage in basic research and testing activities, and as it is equipped with a HEPA filter, the cabinet provides better protection to products, personnel, and the environment. With the growing establishment of R&D facilities for new drug production and testing, the demand for such cabinets is also expected to increase. Furthermore, owing to various investments in R&D for new drug development, the demand for class II biological safety cabinets is also projected to increase.

Asia Pacific is anticipated to be the major regional market.

The Asia Pacific biological safety cabinet (BSC) market is driven by various factors that coincide with the rapidly expanding fields of biotechnology and life sciences research. Strong biosafety protocols must be put in place since the number of facilities conducting genetic research, medication development, and diagnostics is rapidly growing in the area. The need for BSCs is further fueled by government programs and significant expenditures in research and development, which are in line with the region's commitment to promoting innovation and scientific developments.

Healthcare institutions and laboratories are incorporating BSCs into their safety measures because of the growing awareness of the possible hazards involved in handling biological materials and the requirement to adhere to international biosafety standards. The dynamic field of scientific research in the Asia Pacific area highlights the importance of BSCs as essential instruments for guaranteeing a safe workplace, thus fostering the expansion and improvement of biosafety protocols in many sectors.

Key Developments:

In June 2023, the labculture(R) G4 Class II Type A2 Biological Safety Cabinet (LA2 G4) raised the bar for innovation and perfection in biosafety cabinet technology. This state-of-the-art biosafety cabinet, an NSF-certified BSC, established a new benchmark for efficiency and safety. It is made to guarantee the protection of both users and products while offering an exceptional degree of containment.
In March 2023, with the advent of the ReVoTM, an additional cutting-edge microbiological safety cabinet, Labconco(R) expanded its wide range of biosafety products. ReVo is a new Class II, Type A2 biosafety solution that has been carefully designed.

Segmentation:

By Class Type

Class I
Class II
Class III

By Application

Pathogenic Samples Handling
Research & Development Applications

By End-User

Testing & Diagnostic Laboratories
Research Institutes

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
Japan
India
South Korea
Taiwan
Thailand
Indonesia
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings
3.2. Analyst View

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View

5. BIOLOGICAL SAFETY CABINET MARKET, BY CLASS TYPE

5.1. Introduction
5.2. Class I
- 5.2.1. Market Trends and Opportunities
- 5.2.2. Growth Prospects
5.3. Class II
- 5.3.1. Market Trends and Opportunities
- 5.3.2. Growth Prospects
5.4. Class III
- 5.4.1. Market Trends and Opportunities
- 5.4.2. Growth Prospects

6. BIOLOGICAL SAFETY CABINET MARKET, BY APPLICATION

6.1. Introduction
6.2. Pathogenic Samples Handling
- 6.2.1. Market Trends and Opportunities
- 6.2.2. Growth Prospects
6.3. Research & Development Applications
- 6.3.1. Market Trends and Opportunities
- 6.3.2. Growth Prospects

7. BIOLOGICAL SAFETY CABINET MARKET, BY END-USER

7.1. Introduction
7.2. Testing & Diagnostic Laboratories
- 7.2.1. Market Trends and Opportunities
- 7.2.2. Growth Prospects
7.3. Research Institutes
- 7.3.1. Market Trends and Opportunities
- 7.3.2. Growth Prospects

8. BIOLOGICAL SAFETY CABINET MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
  - 8.2.1.1. Market Trends and Opportunities
  - 8.2.1.2. Growth Prospects
- 8.2.2. Canada
  - 8.2.2.1. Market Trends and Opportunities
  - 8.2.2.2. Growth Prospects
- 8.2.3. Mexico
  - 8.2.3.1. Market Trends and Opportunities
  - 8.2.3.2. Growth Prospects
8.3. South America
- 8.3.1. Brazil
  - 8.3.1.1. Market Trends and Opportunities
  - 8.3.1.2. Growth Prospects
- 8.3.2. Argentina
  - 8.3.2.1. Market Trends and Opportunities
  - 8.3.2.2. Growth Prospects
- 8.3.3. Others
  - 8.3.3.1. Market Trends and Opportunities
  - 8.3.3.2. Growth Prospects
8.4. Europe
- 8.4.1. United Kingdom
  - 8.4.1.1. Market Trends and Opportunities
  - 8.4.1.2. Growth Prospects
- 8.4.2. Germany
  - 8.4.2.1. Market Trends and Opportunities
  - 8.4.2.2. Growth Prospects
- 8.4.3. France
  - 8.4.3.1. Market Trends and Opportunities
  - 8.4.3.2. Growth Prospects
- 8.4.4. Spain
  - 8.4.4.1. Market Trends and Opportunities
  - 8.4.4.2. Growth Prospects
- 8.4.5. Others
  - 8.4.5.1. Market Trends and Opportunities
  - 8.4.5.2. Growth Prospects
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
  - 8.5.1.1. Market Trends and Opportunities
  - 8.5.1.2. Growth Prospects
- 8.5.2. UAE
  - 8.5.2.1. Market Trends and Opportunities
  - 8.5.2.2. Growth Prospects
- 8.5.3. Israel
  - 8.5.3.1. Market Trends and Opportunities
  - 8.5.3.2. Growth Prospects
- 8.5.4. Others
  - 8.5.4.1. Market Trends and Opportunities
  - 8.5.4.2. Growth Prospects
8.6. Asia Pacific
- 8.6.1. China
  - 8.6.1.1. Market Trends and Opportunities
  - 8.6.1.2. Growth Prospects
- 8.6.2. Japan
  - 8.6.2.1. Market Trends and Opportunities
  - 8.6.2.2. Growth Prospects
- 8.6.3. India
  - 8.6.3.1. Market Trends and Opportunities
  - 8.6.3.2. Growth Prospects
- 8.6.4. South Korea
  - 8.6.4.1. Market Trends and Opportunities
  - 8.6.4.2. Growth Prospects
- 8.6.5. Taiwan
  - 8.6.5.1. Market Trends and Opportunities
  - 8.6.5.2. Growth Prospects
- 8.6.6. Thailand
  - 8.6.6.1. Market Trends and Opportunities
  - 8.6.6.2. Growth Prospects
- 8.6.7. Indonesia
  - 8.6.7.1. Market Trends and Opportunities
  - 8.6.7.2. Growth Prospects
- 8.6.8. Others
  - 8.6.8.1. Market Trends and Opportunities
  - 8.6.8.2. Growth Prospects